Follow


Submissions from 2021

PDF

Outcomes of patients with thrombocytopenia evaluated at hematology subspecialty clinics, Zaid H. Abdel Rahman, Kevin C. Miller, H Jabbour, Yaser Alkhatib, and Vijayalakshmi Donthireddy

PDF

Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents, Mohamed Alhamar, Bassam Alkamachi, Harshita Mehrotra, Jessica Sanchez, Haythem Y. Ali, Daniel Schultz, and Dhananjay A. Chitale

PDF

Acquired Resistance to KRAS (G12C) Inhibition in Cancer, Mark M. Awad, Shengwu Liu, Igor I. Rybkin, Kathryn C. Arbour, Julien Dilly, Viola W. Zhu, Melissa L. Johnson, Rebecca S. Heist, Tejas Patil, Gregory J. Riely, Joseph O. Jacobson, Xiaoping Yang, Nicole S. Persky, David E. Root, Kristen E. Lowder, Hanrong Feng, Shannon S. Zhang, Kevin M. Haigis, Yin P. Hung, Lynette M. Sholl, Brian M. Wolpin, Julie Wiese, Jason Christiansen, Jessica Lee, Alexa B. Schrock, Lee P. Lim, Kavita Garg, Mark Li, Lars D. Engstrom, Laura Waters, J. David Lawson, Peter Olson, Piro Lito, Sai-Hong I. Ou, James G. Christensen, Pasi A. Jänne, and Andrew J. Aguirre

PDF

A Case of Chronic Eosinophilic Leukemia in a Patient With Recurrent Cough, Dyspnea, and Eosinophilia, Nino Balanchivadze, James P. Purtell, Jessica Anderson, Yue Guo, and Irina Dobrosotskaya

PDF

NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer, Julie E. Bauman, Jonathan Harris, Ravindra Uppaluri, Min Yao, Robert L. Ferris, Josephine Chen, Richard C. Jordan, Nikhil P. Joshi, Srinivas Jujjuvaparu, Dukagjin M. Blakaj, Christina Henson, Jawad Sheqwara, Loren K. Mell, Neilayan Sen, David A. Clump, Madhur K. Garg, Emrullah Yilmaz, Pedro Torres-Saavedra, and Quynh-Thu Le

PDF

Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer, Tru-Khang T. Dinh, Timur Mitin, Hilary P. Bagshaw, Karen E. Hoffman, Clara Hwang, R. Jeffrey Karnes, Amar U. Kishan, Stanley L. Liauw, Shane Lloyd, Louis Potters, Timothy N. Showalter, Al V. Taira, Neha Vapiwala, Nicholas G. Zaorsky, Anthony V. D'Amico, Paul L. Nguyen, and Brian J. Davis

Link

Patient-Reported Outcomes in the Era of Immunotherapy Trials, Shirish M. Gadgeel

PDF

Fast progression in non-small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxel, David Gandara, Martin Reck, Denis Moro-Sibilot, Julien Mazieres, Shirish M. Gadgeel, Stefanie Morris, Andres Cardona, Diana Mendus, Marcus Ballinger, Achim Rittmeyer, and Solange Peters

PDF

Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189, Edward B. Garon, Joachim Aerts, Jong Seok Kim, Catherine E Muehlenbein, Patrick Peterson, Maria Teresa Rizzo, and Shirish M. Gadgeel

PDF

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium, P Grivas, A R Khaki, T M Wise-Draper, B French, C Hennessy, C-Y Hsu, Y Shyr, X Li, T K Choueiri, C A Painter, S Peters, B I Rini, M A Thompson, S Mishra, D R Rivera, J D Acoba, M Z Abidi, Z Bakouny, B Bashir, T Bekaii-Saab, S Berg, E H Bernicker, M A Bilen, P Bindal, R Bishnoi, N Bouganim, D W Bowles, A Cabal, P F Caimi, D D Chism, J Crowell, C Curran, A Desai, B Dixon, D B Doroshow, E B Durbin, A Elkrief, D Farmakiotis, A Fazio, L A Fecher, D B Flora, C R Friese, J Fu, Shirish M. Gadgeel, M D Galsky, D M Gill, M J Glover, S Goyal, P Grover, S Gulati, S Gupta, S Halabi, T R Halfdanarson, B Halmos, D J Hausrath, J E Hawley, E Hsu, M Huynh-Le, Clara Hwang, C Jani, A Jayaraj, D B Johnson, A Kasi, H Khan, V S Koshkin, N M Kuderer, D H Kwon, P E Lammers, A Li, A Loaiza-Bonilla, C A Low, M B Lustberg, G H Lyman, R R McKay, C McNair, H Menon, R A Mesa, V Mico, D Mundt, G Nagaraj, E S Nakasone, J Nakayama, A Nizam, N L Nock, C Park, J M Patel, K G Patel, P Peddi, N A Pennell, A J Piper-Vallillo, M Puc, D Ravindranathan, M E Reeves, D Y Reuben, L Rosenstein, R P Rosovsky, S M Rubinstein, M Salazar, A L Schmidt, G K Schwartz, M R Shah, S A Shah, C Shah, J A Shaya, Sunny R.K. Singh, M Smits, K E Stockerl-Goldstein, D G Stover, M Streckfuss, S Subbiah, L Tachiki, E Tadesse, A Thakkar, M D Tucker, A K Verma, D C Vinh, M Weiss, J T Wu, E Wulff-Burchfield, Z Xie, P P Yu, T Zhang, A Y Zhou, H Zhu, L Zubiri, D P Shah, J L Warner, and GdL Lopes

PDF

Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK + advanced tumors, Felipe K. Hurtado, Filippo de Braud, Javier De Castro Carpeño, Maria Jose de Miguel Luken, Ding Wang, Jeffrey Scott, Yvonne Y. Lau, Tracey McCulloch, and Morten Mau-Sorensen

PDF

Rapid real-world data analysis of patients with cancer, with and without COVID-19, across distinct health systems, Clara Hwang, Monika A. Izano, Michael A. Thompson, Shirish M. Gadgeel, James L. Weese, Tom Mikkelsen, Andrew Schrag, Mahder Teka, Sheetal Walters, Frank M. Wolf, Jonathan Hirsch, Donna R. Rivera, Paul G. Kluetz, Harpreet Singh, and Thomas D. Brown

PDF

Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry, Evelyn M. Jiagge, Peter J. Ulintz, Shukmei Wong, Sean P. McDermott, Sabrina I. Fossi, Tahra K. Suhan, Mark J. Hoenerhoff, Jessica M. Bensenhaver, Barbara Salem, Michele Dziubinski, Joseph K. Oppong, Francis Aitpillah, Kyei Ishmael, Ernest Osei-Bonsu, Ernest Adjei, Awuah Baffour, Jessica Aldrich, Ahmet Kurdoglu, Kurt Fernando, David W. Craig, Jeff M. Trent, Jun Li, Dhananjay A. Chitale, Lisa A. Newman, John D. Carpten, Max S. Wicha, and Sofia D. Merajver

PDF

Apolipoprotein E promotes immune suppression in pancreatic cancer through NF-kB-mediated production of CXCL1, Samantha B. Kemp, Eileen S. Carpenter, Nina G. Steele, Katelyn L. Donahue, Zeribe Chike Nwosu, Amanda Pacheco, Ashley Velez-Delgado, Rosa E. Menjivar, Fatima Lima, Stephanie The, Carlos E. Espinoza, Kristee Brown, Daniel Long, Costas A. Lyssiotis, Arvind Rao, Yaqing Zhang, Marina Pasca di Magliano, and Howard C. Crawford

PDF

Outcomes of in-hospital cardiopulmonary resuscitation for cardiac arrest in adult patients with metastatic solid cancers: A Nationwide Inpatient Sample database analysis from 2012 to 2014, Sindhu Malapati, Sunny R.K. Singh, Rohit Kumar, and Tarik Hadid

PDF

Evolution of the Cancer Registrar in the Era of Informatics, Kelly W. Merriman, Ronda G. Broome, Giordana De Las Pozas, Lisa D. Landvogt, Ying Qi, and Judith Keating

PDF

Adenoid cystic carcinoma of the labium oris with rare metastasis to the pleural cavity, Osama Mosalem, Anas Alsara, Fawzi Abu Rous, and Borys Hrinczenko

Link

Impact of Oral Chemotherapy Management Program on Capecitabine Toxicity Management, Salin Nhean, Diana Kostoff, Jessica J. Yang, Vishnuprabha Vogel, and Igor I. Rybkin

Link

Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors, Angel Qin, Songzhu Zhao, Abdul Miah, Lai Wei, Sandipkumar Patel, Andrew Johns, Madison Grogan, Erin M. Bertino, Kai He, Peter G. Shields, Gregory P. Kalemkerian, Shirish M. Gadgeel, Nithya Ramnath, Bryan J. Schneider, Khaled A. Hassan, Nicholas Szerlip, Zoey Chopra, Sara Journey, Jessica Waninger, Daniel Spakowicz, David P. Carbone, Carolyn J. Presley, Gregory A. Otterson, Michael D. Green, and Dwight H. Owen

PDF

Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations From a Phase 1/2 Trial, Gregory J. Riely, Joel W. Neal, D. Ross Camidge, Alexander I. Spira, Zofia Piotrowska, Daniel B. Costa, Anne S. Tsao, Jyoti D. Patel, Shirish M. Gadgeel, Lyudmila Bazhenova, Viola W. Zhu, Howard L. West, Tarek Mekhail, Ryan D. Gentzler, Danny Nguyen, Sylvie Vincent, Steven Zhang, Jianchang Lin, Veronica Bunn, Shu Jin, Shuanglian Li, and Pasi A. Janne

PDF

Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural), Amy D. Shapiro, Margaret V. Ragni, Munira Borhany, Yasmina L. Abajas, Michael D. Tarantino, Katharina Holstein, Stacy E. Croteau, Riana Liesner, Cristina Tarango, Manuela Carvalho, Catherine McGuinn, Eva Funding, Christine L. Kempton, Christoph Bidlingmaier, Alice Cohen, Johannes Oldenburg, Susan Kearney, Christine Knoll, Philip Kuriakose, Suchitra Acharya, Ulrike M. Reiss, Roshni Kulkarni, Michelle Witkop, Stefan Lethagen, Sharyne Donfield, Petra LeBeau, Erik Berntorp, and Jan Astermark

PDF

NCDB analysis of melanoma 2004–2015: Epidemiology and outcomes by subtype, sociodemographic factors impacting clinical presentation, and real‐world survival benefit of immunotherapy approval, Sunny R.K. Singh, Sindhu J. Malapati, Rohit Kumar, Christopher Willner, and Ding Wang

PDF

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort, Benjamin Tan, Adnan Khattak, Enriqueta Felip, Karen Kelly, Patricia Rich, Ding Wang, Christoph Helwig, Isabelle Dussault, Laureen S. Ojalvo, and Nicolas Isambert

PDF

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19, Michael A. Thompson, Jeffrey P. Henderson, Pankil K. Shah, Samuel M. Rubinstein, Michael J. Joyner, Toni K. Choueiri, Daniel B. Flora, Elizabeth A. Griffiths, Anthony P. Gulati, Clara Hwang, Vadim S. Koshkin, Esperanza B. Papadopoulos, Elizabeth V. Robilotti, Christopher T. Su, Elizabeth M. Wulff-Burchfield, Zhuoer Xie, Peter Paul Yu, Sanjay Mishra, Jonathon W. Senefeld, Dimpy P. Shah, and Jeremy L. Warner

PDF

Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Clinical Trial, Ulka N. Vaishampayan, Lance K. Heilbrun, Paul Monk, Sheela Tejwani, Guru Sonpavde, Clara Hwang, Daryn Smith, Pallavi Jasti, Kimberlee Dobson, Brenda Dickow, Elisabeth I. Heath, Louie Semaan, Michael L. Cher, Joseph A. Fontana, and Sreenivasa Chinni

Submissions from 2020

PDF

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis, Andrea B. Apolo, John A. Ellerton, Jeffrey R. Infante, Manish Agrawal, Michael S. Gordon, Raid Aljumaily, Theodore Gourdin, Luc Dirix, Keun-Wook Lee, Matthew H. Taylor, Patrick Schöffski, Ding Wang, Alain Ravaud, Juliane Manitz, Gregory Pennock, Mary Ruisi, James L. Gulley, and Manish R. Patel

Link

Heterogeneity at the invasion front of triple negative breast cancer cells, Koh Meng Aw Yong, Peter J. Ulintz, Sara Caceres, Xu Cheng, Liwei Bao, Zhifen Wu, Evelyn M. Jiagge, and Sofia D. Merajver

Link

Hematology/Oncology Fellowship Emergency Restructuring in Response to the COVID-19 Pandemic—Henry Ford Hospital, Michigan, Nino Balanchivadze and Vijayalakshmi Donthireddy

Link

Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease One Center Urban Experience, Detroit, MI, USA, Nino Balanchivadze, Adam A. Kudirka, Sally FK Askar, Khaled Almadhoun, Philip Kuriakose, Raef Fadel, and Vrushali Dabak

PDF

American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020, Stephen G. Chun, Charles B. Simone, Arya Amini, Indrin J. Chetty, Jessica Donington, Martin J. Edelman, Kristin A. Higgins, Larry L. Kestin, Benjamin Movsas, George B. Rodrigues, Kenneth E. Rosenzweig, Ben J. Slotman, Igor I. Rybkin, Andrea Wolf, and Joe Y. Chang

Link

Synthesis, Cytotoxicity, and Genotoxicity of 10-Aza-9-oxakalkitoxin, an N,N,O-Trisubstituted Hydroxylamine Analog, or Hydroxalog, of a Marine Natural Product, Sandeep Dhanju, Kapil Upadhyaya, Christopher A. Rice, Scott D. Pegan, Joe Media, Frederick A. Valeriote, and David Crich

Link

Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study, Susan M. Domchek, Sophie Postel-Vinay, Seock-Ah Im, Yeon Hee Park, Jean-Pierre Delord, Antoine Italiano, Jerome Alexandre, Benoit You, Sara Bastian, Matthew G Krebs, Ding Wang, Saiama N. Waqar, Mark Lanasa, Joon Rhee, Haiyan Gao, Vidalba Rocher-Ros, Emma V. Jones, Sakshi Gulati, Anna Coenen-Stass, Iwanka Kozarewa, Zhongwu Lai, Helen K. Angell, Laura Opincar, Pia Herbolsheimer, and Bella Kaufman

Link

Using whole breast ultrasound tomography to improve breast cancer risk assessment: A novel risk factor based on the quantitative tissue property of sound speed, Neb Duric, Mark Sak, Shaoqi Fan, Ruth M. Pfeiffer, Peter J. Littrup, Michael S. Simon, David H. Gorski, Haythem Y. Ali, Kristen S. Purrington, Rachel F. Brem, Mark E. Sherman, and Gretchen L. Gierach

Link

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry, Zhaohui Du, Niels Weinhold, Gregory C. Song, Kristin A. Rand, David J. Van Den Berg, Amie E. Hwang, Xin Sheng, Victor Hom, Sikander Ailawadhi, Ajay K. Nooka, Seema Singhal, Karen Pawlish, Edward S. Peters, Cathryn Bock, Ann Mohrbacher, Alexander Stram, Sonja I. Berndt, William J. Blot, Graham Casey, Victoria L. Stevens, Rick Kittles, Phyllis J. Goodman, W R. Diver, Anselm Hennis, Barbara Nemesure, Eric A. Klein, Benjamin A. Rybicki, Janet L. Stanford, John S. Witte, Lisa Signorello, Esther M. John, Leslie Bernstein, Antoinette M Stroup, Owen W Stephens, Maurizio Zangari, Frits Van Rhee, Andrew Olshan, Wei Zheng, Jennifer J Hu, Regina Ziegler, Sarah J Nyante, Sue Ann Ingles, Michael F Press, John David Carpten, Stephen J Chanock, Jayesh Mehta, Graham A Colditz, Jeffrey Wolf, Thomas G Martin, Michael Tomasson, Mark A Fiala, Howard Terebelo, Nalini Janakiraman, Laurence Kolonel, Kenneth C Anderson, Loic Le Marchand, Daniel Auclair, Brian C-H Chiu, Elad Ziv, Daniel Stram, Ravi Vij, Leon Bernal-Mizrachi, Gareth J Morgan, Jeffrey A Zonder, Carol Ann Huff, Sagar Lonial, Robert Z Orlowski, David V Conti, Christopher A Haiman, and Wendy Cozen

Link

Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for High Risk Low-Grade Gliomas: Long-term Results of Radiation Therapy Oncology Group (RTOG) 0424, Barbara J. Fisher, Stephanie L. Pugh, David R. Macdonald, Arnab Chakravatri, Glenn J. Lesser, Sherry Fox, C L. Rogers, Maria Werner-Wasik, Thomas Doyle, Jean-Paul Bahary, John B. Fiveash, Joseph A. Bovi, Steven P. Howard, Hsiang-Hsuan Michael Yu, David D'Souza, Nadia N. Laack, Igor J. Barani, Young Kwok, Daniel R. Wahl, Jon F. Strasser, Minhee Won, and Minesh P. Mehta

Link

Electrocardiographic Changes Associated With Ibrutinib Exposure, Michael G. Fradley, Allan Welter-Frost, Matthew Gliksman, Josephine Emole, Federico Viganego, Dae Hyun Lee, Bijal Shah, Julio C. Chavez, Javier Pinilla-Ibarz, and Matthew B. Schabath

Link

Neratinib plus Cetuximab in Quadruple WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study, Samuel A. Jacobs, James J. Lee, Thomas J. George, James L. Wade, Philip J. Stella, Ding Wang, Ashwin Sama, Fanny Piette, Katherine L Pogue-Geile, Rim S. Kim, Patrick G. Gavin, Corey Lipchik, Huichen Feng, Ying Wang, Melanie Finnigan, Brian Kiesel, Jan H. Beumer, Norman Wolmark, Peter C. Lucas, Carmen J. Allegra, and Ashok Srinivasan

Link

Reinvestigation of Mycothiazole Reveals the Penta-2,4-dien-1-ol Residue Imparts Picomolar Potency and 8, Tyler A. Johnson, Joseph D. Morris, David A. Coppage, Colon V. Cook, Lauren N. Persi, Marcos A. Ogarrio, Taylor C. Garcia, Nicole L. McIntosh, Erin P. McCauley, Joe Media, Mani Maheshwari, Frederick A. Valeriote, Jiajiu Shaw, and Phillip Crews

Link

Is the HERV-K HML-2 Xq2133, an endogenous retrovirus mutated by gene conversion of chromosome X in a subset of African populations, associated with human breast cancer?, Mark H. Kaplan, Rafael Contreras-Galindo, Evelyn M. Jiagge, Sofia D. Merajver, Lisa Newman, Galya Bigman, Michael H. Dosik, Ganesh S. Palapattu, Javed Siddiqui, Arul M. Chinnaiyan, Sally Adebamowo, and Clement Adebamowo

Link

BRAINSTORM: A Multi-Institutional Phase I/II Study of RRx-001 in Combination with Whole Brain Radiation Therapy for Patients with Brain Metastases, Michelle M Kim, Hemant A Parmar, Matthew Schipper, Theresa Devasia, Madhava P Aryal, Santosh Kesari, Steven O'Day, Aki Morikawa, Daniel E Spratt, Larry Junck, Aaron Mammoser, James A Hayman, Theodore S Lawrence, Christina I Tsien, Robert Aiken, Sharad Goyal, Nacer Abrouk, Malcolm Trimble, Yue Cao, and Christopher D. Lao

Link

Incidence and outcomes of heparin-induced thrombocytopenia in solid malignancy: an analysis of the National Inpatient Sample Database, Rohit Kumar, Shruti Bhandari, Sukhpreet RK Singh, Sindhu Malapati, and Kamila I. Cisak

Link

Poroid Hidradenoma; a Benign Lesion Masking as Malignant Breast Tumor, Hassan Liaqat, Mohammad Ammad Ud Din, and Devin Malik

PDF

Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia, Lucas G. Maahs, Amy Tang, Zaid Al-Saheli, Brigid Jacob, Rishika Polasani, and Clara Hwang

PDF

Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC: Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials, Julien Mazieres, Achim Rittmeyer, Shirish M. Gadgeel, Toyoaki Hida, David R. Gandara, Diego L. Cortinovis, Fabrice Barlesi, Wei Yu, Christina Matheny, Marcus Ballinger, and Keunchil Park

PDF

Outcomes According to ALK Status Determined by Central Immunohistochemistry or Fluorescence In Situ Hybridization in Patients With ALK-Positive NSCLC Enrolled in the Phase 3 ALEX Study, Tony Mok, Solange Peters, D. Ross Camidge, Johannes Noé, Shirish M. Gadgeel, Sai-Hong I. Ou, Dong-Wan Kim, Krzysztof Konopa, Emanuela Pozzi, Ting Liu, Isabell R. Loftin, Crystal Williams, and Alice T. Shaw

Link

Bilateral breast masses as a presentation for T-cell acute lymphoblastic leukaemia, Osama Mosalem, Fawzi Abu Rous, Ahmed Elshafie, and Daniel Isaac

Link

Pulmonary embolism as the primary presentation of IgA vasculitis, Osama Mosalem, Nora Hernandez Garcilazo, Yehia Saleh, and Fawzi Abu Rous

Link

A user's guide to lorlatinib, Misako Nagasaka, Yubin Ge, Ammar Sukari, Geetika Kukreja, and Sai-Hong Ignatius Ou

Link

Predictors of response and outcome of patients with acquired haemophilia A, Ifeoma Onwubiko, Gary Kasperek, Rosarina A. Laforest, Samuel G. Philip, Philip Kuriakose, and Zaher K. Otrock

Link

Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection, Neha R. Patil, Erica S. Herc, and Marian R. Girgis

Link

Exceptional Response to A Single Cycle of Immunotherapy in a Lynch Syndrome Patient with Metastatic Pancreatic Adenocarcinoma, Neha R. Patil and Gazala N. Khan

Link

Primary Pleural Extranodal Marginal Zone Lymphoma Presenting as Bilateral Chylothorax, Thushara Paul, Dhiraj K. Yadav, Mohamed Alhamar, and Vrushali Dabak

Link

Molecular therapeutic targets in non-small cell lung cancer, Kamya Sankar, Shirish M. Gadgeel, and Angel Qin

Link

A Versatile Chemoenzymatic Synthesis for the Discovery of Potent Cryptophycin Analogs, Jennifer J Schmidt, Yogan Khatri, Scott I Brody, Catherine Zhu, Halina Pietraszkiewicz, Frederick A. Valeriote, and David H. Sherman

Link

Toxicity in combination immune checkpoint inhibitor and radiation therapy: a systematic review and meta-analysis, Congzhou M Sha, Eric J. Lehrer, Clara Hwang, Daniel M. Trifiletti, Heath B. Mackley, Joseph J. Drabick, and Nicholas G. Zaorsky

PDF

Desperate times, desperate measures: successful use of chemotherapy in treatment of haemophagocytic lymphohistiocytosis (HLH) due to disseminated histoplasmosis., Sunny RK Singh, Kannan Thanikachalam, and Vijayalakshmi Donthireddy

Link

COVID-19 and Cancer: Lessons Learnt from a Michigan Hotspot, Sunny RK Singh, Kannan Thanikachalam, Hiba Jabbour Aida, Laila M. Poisson, and Gazala Khan

Link

Pseudo-Thrombocytosis Caused by Extreme Microcytosis in a Patient with Alpha Thalassemia Trait, Alexander A. Slota, Devin Malik, and Diane Hall

Link

Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant, Scott R. Solomon, Andrew St. Martin, Mei-Jie Zhang, Karen Ballen, Asad Bashey, Minoo Battiwalla, Lee Ann Baxter-Lowe, Claudio Brunstein, Saurabh Chhabra, Miguel Perez, Ephraim J. Fuchs, Siddhartha Ganguly, Nancy Hardy, Peiman Hematti, Joseph McGuirk, Edward Peres, Olle Ringden, David Rizzieri, Rizwan Romee, Melhem Solh, David Szwajcer, Marjolein van der Poel, Edmund Waller, Basem M. William, and Mary Eapen

Link

Brief Report: Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination with Pegilodecakin in Patients with Metastatic Non-Small-Cell Lung Cancer (CYPRESS-1 and CYPRESS-2), David Spigel, Robert Jotte, John Nemunaitis, Merrill Shum, Jeffrey Schneider, Jerome Goldschmidt, Jennifer Eisenstein, David Berz, Lasika Seneviratne, Matei Socoteanu, Viralkumar Bhanderi, Kartik Konduri, Meng Xia, Hong Wang, Rebecca R Hozak, Ivelina Gueorguieva, David Ferry, Leena Gandhi, Bo H Chao, and Igor Rybkin

Link

The role of immune checkpoint inhibitors in anaplastic thyroid cancer (Case Series), Ammar Sukari, Geetika Kukreja, Misako Nagasaka, Mohammad K. Shukairy, George Yoo, Ho-Sheng Lin, Jeffrey Hotaling, and Harold Kim

PDF

Disparities in the Uptake of Telemedicine During the COVID-19 Surge in a Multidisciplinary Head and Neck Cancer Population by Patient Demographic Characteristics and Socioeconomic Status, Samantha Tam, Vivian Wu, Amy M. Williams, Marian R. Girgis, Jawad Z. Sheqwara, Farzan Siddiqui, and Steven S. Chang

Link

Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer, Kannan Thanikachalam, Vijay Damarla, Trevor Seixas, Irina Dobrosotskaya, Ira Wollner, David Kwon, Kenneth Winters, Mohammad Raoufi, Jia Li, Farzan Siddiqui, and Gazala Khan

PDF

Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study, Claire F. Verschraegen, Guy Jerusalem, Edward F. McClay, Nicholas Iannotti, Charles H. Redfern, Jaafar Bennouna, Franklin L. Chen, Karen Kelly, Janice Mehnert, John C. Morris, Matthew Taylor, David Spigel, Ding Wang, Hans Juergen Grote, Dongli Zhou, Neru Munshi, Marcis Bajars, and James L. Gulley

PDF

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer, Martin H. Voss, Michael S. Gordon, Monica Mita, Brian Rini, Vicky Makker, Teresa Macarulla, David C. Smith, Andrés Cervantes, Igor Puzanov, Roberto Pili, Ding Wang, Shadia Jalal, Shubham Pant, Manish R. Patel, Rachel L. Neuwirth, Aaron Enke, Yaping Shou, Farhad Sedarati, Douglas V. Faller, and Howard A. Burris

Link

Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United States, Yang Yu, Niquelle Brown Wade, Amie E. Hwang, Ajay K. Nooka, Mark A. Fiala, Ann Mohrbacher, Edward S. Peters, Karen Pawlish, Cathryn Bock, David J. Van Den Berg, Kristin A. Rand, Daniel Stram, David V. Conti, Daniel Auclair, Graham A. Colditz, Jayesh Mehta, Christopher A. Haiman, Howard Terebelo, Nalini Janakiraman, Seema Singhal, Brian Chiu, Ravi Vij, Leon Bernal-Mizrachi, Jeffrey A. Zonder, Carol A. Huff, Sagar Lonial, Robert Z. Orlowski, Wendy Cozen, and Sikander Ailawadhi

Submissions from 2019

Link

Exploration of the carmaphycins as payloads in antibody drug conjugate anticancer agents, Jehad Almaliti, Bailey Miller, Halina Pietraszkiewicz, Evgenia Glukhov, C B. Naman, Toni Kline, Jeffrey Hanson, Xiaofan Li, Sihong Zhou, Frederick A. Valeriote, and William H. Gerwick

Link

Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysis, Jesus G. Berdeja, Michael C. Heinrich, Shaker R. Dakhil, Stuart L. Goldberg, Martha Wadleigh, Philip Kuriakose, Jorge Cortes, Jerald Radich, Bret Helton, David Rizzieri, Carole Paley, Ilva Dautaj, and Michael J. Mauro

Link

Highly Convergent Total Synthesis and Assignment of Absolute Configuration of Majusculamide D, a Potent and Selective Cytotoxic Metabolite from Moorea sp, Eduardo JE Caro-Diaz, Frederick A. Valeriote, and William H. Gerwick

Link

A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors, Ezra EW Cohen, Michael J. Pishvaian, Dale R. Shepard, Ding Wang, Jared Weiss, Melissa L. Johnson, Christine H. Chung, Ying Chen, Bo Huang, Craig B. Davis, Francesca Toffalorio, Aron Thall, and Steven F. Powell

Link

The effects of lapatinib on cardiac repolarization: results from a placebo controlled, single sequence, crossover study in patients with advanced solid tumors, Shodeinde A. Coker, Herbert I. Hurwitz, Sunil Sharma, Ding Wang, Pierre Jordaan, Juan P. Zarate, and Lionel D. Lewis

Link

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105, Alexander Drilon, Siqing Fu, Manish R. Patel, Marwan Fakih, Ding Wang, Anthony J. Olszanski, Daniel Morgensztern, Stephen V. Liu, Byoung C. Cho, Lyudmila Bazhenova, Cristina P. Rodriguez, Robert C. Doebele, Antoinette Wozniak, Karen L. Reckamp, Tara Seery, Petros Nikolinakos, Zheyi Hu, Jennifer W. Oliver, Denise Trone, Katherine McArthur, Rupal Patel, Pratik S. Multani, and Myung-Ju Ahn

Link

Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic Chemotherapy, Michael G. Fradley, Matthew Gliksman, Josephine Emole, Federico Viganego, Isaac Rhea, Allan Welter-Frost, Merna Armanious, Dae-Hyun Lee, Christine Walko, Bijal Shah, Julio C. Chavez, Howard McLeod, Javier Pinilla-Ibarz, and Matthew B. Schabath

Link

The KRAS, Jill Hallin, Lars D. Engstrom, Lauren Hargis, Andrew Calinisan, Ruth Aranda, David M. Briere, Niranjan Sudhakar, Vickie Bowcut, Brian R. Baer, Joshua A. Ballard, Michael R. Burkard, Jay B. Fell, John P. Fischer, Guy P. Vigers, Yaohua Xue, Sole Gatto, Julio Fernandez-Banet, Adam Pavlicek, Karen Velastagui, Richard C. Chao, Jeremy Barton, Mariaelena Pierobon, Elisa Baldelli, Emanuel F. Patricoin, Douglas P. Cassidy, Matthew A. Marx, I Rybkin, Melissa L. Johnson, Sai-Hong I. Ou, Piro Lito, Kyriakos P. Papadopoulos, Pasi A. Jänne, Peter Olson, and James G Christensen

Link

A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment, Meredith C. Henderson, Michael Silver, Quynh Tran, Elias E. Letsios, Rao Mulpuri, David E. Reese, Ana P. Lourenco, Joshua LaBaer, Karen S. Anderson, Josie Alpers, Carrie Costantini, Nitin Rohatgi, Haythem Y. Ali, Karen Baker, Donald W. Northfelt, Karthik Ghosh, Stephen R. Grobmyer, Winnie Polen, and Judith K. Wolf

PDF

Evaluation of a Multidisciplinary Team Approach for Generating Survivorship Care Plan Treatment Summaries in Patients With Breast Cancer, Tommy Ivanics, Erica Proctor, Yalei Chen, Haythem Y. Ali, Dawn Severson, Hassan Nasser, Sonja Colbert, Laura L. Susick, Eleanor Walker, Lindsay Petersen, Jessica Bensenhaver, Randa Loutfi, S David Nathanson, and Lisa A. Newman

Link

Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry, Brittany D. Jenkins, Rachel N. Martini, Rupali Hire, Andrea Brown, Briana Bennett, I'nasia Brown, Elizabeth W. Howerth, Mary Egan, Jamie Hodgson, Clayton Yates, Rick Kittles, Dhananjay A. Chitale, Haythem Y. Ali, S David Nathanson, Petros Nikolinakos, Lisa A. Newman, Michele Monteil, and Melissa B. Davis

Link

Evaluation of the impact of thyroiditis development in patients receiving immunotherapy with programmed cell death-1 inhibitors, Matthew Lei, Angela Michael, Seema Patel, and Ding Wang

Link

The role of a low erythropoietin level for the polycythemia vera diagnosis, Oleksandra Lupak, Xiaoxia Han, Peter Xie, Sharmeen Mahmood, Hadi Mohammed, and Vijayalakshmi Donthireddy

Link

Class III β-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer, Lucas G. Maahs, Bertha E. Sanchez, Nilesh S. Gupta, Meredith Van Harn, Evelyn R. Barrack, Prem-Veer Reddy, and Clara Hwang

Link

RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer, Daniel Morgensztern, Michal Rose, Saiama N. Waqar, John Morris, Patrick C. Ma, Thomas Reid, Christina E. Brzezniak, Karen G. Zeman, Arvinda Padmanabhan, JoAnn Hirth, Alexander I Spira, Jane B. Trepel, and Sukhmani K. Padda

Link

Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide, Amanda B. Pilling and Clara Hwang

Link

Castration-resistant prostate cancer: Androgen receptor inactivation induces telomere DNA damage, and damage response inhibition leads to cell death, Vidyavathi Reddy, Asm Iskander, Clara Hwang, George Divine, Mani Menon, Evelyn R. Barrack, G Prem-Veer Reddy, and Sahn-Ho Kim

PDF

US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials, Jeanne M. Regnante, Nicole A. Richie, Lola Fashoyin-Aje, Michelle Vichnin, Marvella Ford, Upal B. Roy, Kenneth Turner, Laura L. Hall, Evelyn Gonzalez, Nestor Esnaola, Luther T. Clark, Homer C. Adams, Olatunji B. Alese, Keerthi Gogineni, Lorna McNeill, Daniel Petereit, Ify Sargeant, Julie Dang, Coleman Obasaju, Quita Highsmith, Simon C. Lee, Spencer C. Hoover, Erin L. Williams, and Moon S. Chen

Link

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation, Ayman Saad, Lawrence Lamb, Tao Wang, Michael T. Hemmer, Stephen Spellman, Daniel Couriel, Amin Alousi, Joseph Pidala, Hisham Abdel-Azim, Vaibhav Agrawal, Mahmoud Aljurf, Amer M. Beitinjaneh, Vijaya R. Bhatt, David Buchbinder, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Paul Castillo, Saurabh Chhabra, Miguel A. Diaz, Shatha Farhan, Yngvar Floisand, Hadar A. Frangoul, Shahinaz M. Gadalla, James Gajewski, Robert P. Gale, Manish Gandhi, Usama Gergis, Betty K. Hamilton, Peiman Hematti, Gerhard C. Hildebrandt, Rammurti T. Kamble, Abraham S Kanate, Pooja Khandelwal, Aleksandr Lazaryn, Margaret MacMillan, David I Marks, Rodrigo Martino, Parinda A Mehta, Taiga Nishihori, Richard F Olsson, Sagar S Patel, Muna Qayed, Hemalatha G Rangarajan, Ran Reshef, Olle Ringden, Bipin N Savani, Harry C Schouten, Kirk R Schultz, Sachiko Seo, Brian C Shaffer, Melhem Solh, Takanori Teshima, Alvaro Urbano-Ispizua, Leo F Verdonck, Ravi Vij, Edmund K Waller, Basem William, Baldeep Wirk, Jean A Yared, Lolie C Yu, Mukta Arora, and Shahrukh Hashmi

Link

Colorectal Cancer and Nutrition, Kannan Thanikachalam and Gazala Khan

Link

Development of an algorithm for the systematic evaluation of patients with suspected heparin-induced thrombocytopenia, Julie Thomson, Philip Kuriakose, Long To, Michael Peters, and James Kalus

Link

A rare case of follicular lymphoma transformed to a high-grade B-cell lymphoma in orbit, Raju K. Vaddepally, Amal Hejab, Vrushali Dabak, and Madhu P. Menon

Link

Computationally Assisted Discovery and Assignment of a Highly Strained and PANC-1 Selective Alkaloid from Alaska's Deep Ocean, Yike Zou, Xiaojuan Wang, James Sims, Bin Wang, Pankaj Pandey, Colin L. Welsh, Robert P. Stone, Mitchell A. Avery, Robert J. Doerksen, Daneel Ferreira, Clemens Anklin, Frederick A. Valeriote, Michelle Kelly, and Mark T. Hamann

Submissions from 2018

PDF

A Lesion on the Scalp, Zaid Abdel-Rahman, Kedar Inamdar, and Haythem Y. Ali

Link

Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer, Aditya Bardia, Ayca Gucalp, Noashir DaCosta, Nashat Gabrail, Michael Danso, Haythem Y. Ali, Kimberly L. Blackwell, Lisa A. Carey, Joel R. Eisner, Edwina S. Baskin-Bey, and Tiffany A. Traina

Link

Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer, Jessica L. Christenson, Jane B. Trepel, Haythem Y. Ali, Sunmin Lee, Joel R. Eisner, Edwina S. Baskin-Bey, Anthony D. Elias, and Jennifer K. Richer

Link

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study, S de Vos, L J. Swinnen, Ding Wang, E Reid, N Fowler, J Cordero, M Dunbar, S H. Enschede, C Nolan, A M. Petrich, J A. Ross, A H. Salem, M Verdugo, S Agarwal, L Zhou, M Kozloff, L J. Nastoupil, and C R. Flowers

Link

Unexplained pancytopenia in acute myeloid leukemia treatment, Daniel Ezekwudo, Oleksandra Lupak, Raju Vaddepally, Bolanle Gbadamosi, and Philip Kuriakose

Link

Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer, R S. Finn, D H. Ahn, M M. Javle, B R. Tan, C D. Weekes, J C. Bendell, A Patnaik, Gazala Khan, D Laheru, R Chavira, J Christy-Bittel, E Barrett, M B. Sawyer, and Tanios S. Bekaii-Saab

Link

A Retrospective Study Analyzing the Appropriateness of Initial Treatment of, Aaron Fisher, Pradeep Khanal, Ewa Gniado, Leila Khaddour, Molly Orosey, Ismail Hader, Siddhartha Yadav, and Alexandra Halalau

Link

Nab-paclitaxel-based therapy in underserved patient populations: The aboundPs2 study in patients with nsclc and a performance status of 2, Ajeet Gajra, Nagla A. Karim, Deborah A. Mulford, Liza C. Villaruz, Marc R. Matrana, Haythem Y. Ali, Edgardo S. Santos, Tymara Berry, Teng J. Ong, Alexandra Sanford, Katayoun Amiri, and David R. Spigel

Link

Management of haemophilia carriers around the time of their delivery: Phenotypic variation requiring customization of management, M R. Girgis, L Gusba, and Philip Kuriakose

Link

Genitourinary Pathology Reporting Parameters Most Relevant to the Medical Oncologist, Clara Hwang

PDF

Enrichment and mutation detection of circulating tumor cells from blood samples, Ruqin Kou, Jian Zhao, Priya Gogoi, Shannon Carskadon, Will Chow, Clara Hwang, Nallasivam Palanisamy, Conrad Leung, and Yixin Wang